CSIR-IICT signs MoU with 101 Therapeutics, Israel for COVID-19 drug EP News Bureau May 8, 2023 CSIR-IICT will be the knowledge partner for the clinical trial study and 101 Therapeutics, a CRO will manufacture the drug
